Review and management of clozapine side effects

Journal of Clinical Psychiatry

Volumn 61, Issue SUPPL. 8, 2000, Pages 14-19

  Miller, Del D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; BENZATROPINE; BENZATROPINE MESILATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLONIDINE; CLOZAPINE; DESMOPRESSIN; EPHEDRINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HALOPERIDOL; LAXATIVE; METHYLPHENIDATE; PHENAZONE; PIRENZEPINE; PROLACTIN; VALPROIC ACID;

AGRANULOCYTOSIS; CONSTIPATION; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEVER; HUMAN; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPERTENSION; HYPOTENSION; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SEIZURE; SOMNOLENCE; TACHYCARDIA; URINE INCONTINENCE; WEIGHT GAIN;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR DISEASES; CLOZAPINE; DRUG MONITORING; HUMANS; RESPIRATION DISORDERS; SEIZURES; SIALORRHEA; WEIGHT GAIN;

EID: 0034077062     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Clozaril (clozapine). Physicians' Desk Reference. 53rd ed. Montvale, NJ: Medical Economics: 1999:2004-2008
2. Kane J, Honigfeld G, Singer J, et al, and the Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine/benztropine. Arch Gen Psychiatry 1988; 45:789-796
3. Breier A, Buchanan RW, Kirkpatrick B, et al. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994;151:20-26
4. Sandoz Inc. Clozari New Drug Application. East Hanover, NJ: Sandoz Pharmaceutical Corp; 1987
5. Lieberman JA, Saltz BL, Johns CA, et al. The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991;158:503-510
6. Spivak B, Mester R, Abesgaus J, et al. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. J Clin Psychiatry 1997;58:318-322
7. Meltzer HY, Goode DJ, Schyve PM, et al. Effect of clozapine on human serum prolactin levels. Am J Psychiatry 1979;136:1550-1555
8. Kane JM, Cooper TB, Sachar EJ, et al. Clozapine: plasma levels and prolactin response. Psychopharmacology 1981;73:184-187
9. Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacol (Berl) 1989;99(suppl):S18-S27
10. Meltzer HY. The mechanism of action of novel antipsychotic drugs. Schizophr Bull 1991;17:263-287
11. Honigfeld G. The Clozapine National Registry System: forty years of risk management. J Clin Psychiatry Monograph 1996;14(2):29-32
12. Alvir JMJ, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis. N Engl J Med 1993;329:162-167
13. Lieberman JA, Yunis J, Egea E, et al. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatry 1990;47:945-948
14. Peacock L, Gerlach J. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices. J Clin Psychiatry 1994;55:44-49
15. Barnas C, Zwierzina H, Hummer M, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report. J Clin Psychiatry 1992;53:245-247
16. Morstyn G, Burgess AW. Hemopoietic growth factors: a review. Cancer Res 1988;48:5624-5637
17. Lamberti JS, Bellnier TJ, Schwarzkopf SB, et al. Filgrastim treatment of three patients with clozapine-induced agranulocytosis. J Clin Psychiatry 1995;56:256-259
18. Lieberman JA, Safferman AZ. Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatr Q 1992;63:51-70
19. Friedman LJ, Tabb SE, Sanchez CJ. Clozapine: a novel antipsychotic agent [letter with reply]. N Engl J Med 1991;325:518-519
20. Toth P, Frankenburg FR. Clozapine and seizures: a review. Can J Psychiatry 1994;39:236-238
21. Burke M, Sebastian CS. Treatment of clozapine sedation [letter]. Am J Psychiatry 1993;150:1900-1901
22. VanderZwaag C, McGee M, McEvoy JP, et al. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges. Am J Psychiatry 1996;153:1579-1584
23. Baldessarini RJ, Frankenburg FR. Clozapine: a novel antipsychotic agent. N Engl J Med 1991;324:746-754
24. Miller SC. Methylphenidate for clozapine sedation [letter]. Am J Psychiatry 1996;153:123-1232
25. Marinkovic D, Timotijevic I, Babinski T, et al. The side effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:537-544
26. Ben-Aryeh H, Jungerman T, Szargel R, et al. Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data. Biol Psychiatry 1996;39:946-949
27. Rabinowitz T, Frankenburg FR, Centorrino F, et al. The effect of clozapine on saliva flow rate: a pilot study. Biol Psychiatry 1996;40:1132-1134
28. Lieberman JA. Maximizing clozapine therapy: managing side effects. J Clin Psychiatry 1998;59(suppl 3):38-43
29. Ereshefsky L, Watanabe MD, Tran-Johnson TK. Clozapine: an atypical antipsychotic agent. Clin Pharm 1989;8:691-709
30. Cohen S, Chiles J, MacNaughton A. Weight gain associated with clozapine. Am J Psychiatry 1990;147:503-504
31. John JP, Chengappa KN, Baker RW, et al. Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients. Ann Clin Psychiatry 1995;7:119-125
32. Leadbetter R, Shutty M, Pavalonis D, et al. Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 1992;149:68-72
33. Hayes G, Gibler G. Clozapine-induced constipation [letter]. Am J Psychiatry 1995;152:298
34. Fuller MA, Borovicka MC, Jaskiw GE, et al. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry 1996;57:514-518